Tenaya Therapeutics, Inc.
TNYANasdaqCIK 1858848HealthcareFiscal year ends Dec 31
Reports and events: 94 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2316:47 ET | DEF 14A | Proxy statementPeriod 2026-12-09 | 0001193125-26-430591 |
| 2026-08-0520:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-335140 |
| 2026-08-0520:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335098 |
| 2026-07-0221:00 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-26-294879 |
| 2026-06-2913:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-286957 |
| 2026-05-2921:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-248680 |
| 2026-05-0620:24 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-209084 |
| 2026-05-0620:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208975 |
| 2026-04-1613:00 ET | DEF 14A | Proxy statementPeriod 2026-05-27 | 0001193125-26-158079 |
| 2026-03-1120:28 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-102252 |
| 2026-03-1120:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-102170 |
| 2026-03-0513:35 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-092654 |
| 2026-02-2621:29 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-076892 |
| 2026-02-1223:52 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-049218 |
| 2026-01-3022:06 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-032017 |
| 2026-01-0222:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-001065 |
| 2025-12-1721:16 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-322770 |
| 2025-12-1221:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-317642 |
| 2025-12-1121:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-315951 |
| 2025-11-1012:12 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-273239 |
| 2025-11-1012:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-273230 |
| 2025-11-0721:24 ET | 8-K | 8.01 Other events | 0001193125-25-272423 |
| 2025-08-0620:50 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104182 |
| 2025-08-0620:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104164 |
| 2025-05-3020:32 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-079773 |
| 2025-05-1420:18 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-071441 |
| 2025-05-0720:27 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-065741 |
| 2025-05-0720:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065703 |
| 2025-04-1821:07 ET | 8-K | 3.01 Delisting notice | 0000950170-25-055927 |
| 2025-04-1720:05 ET | DEF 14A | Proxy statementPeriod 2025-05-28 | 0001193125-25-084313 |
| 2025-03-2820:08 ET | 8-K | 2.05 Exit or disposal costs | 0001193125-25-067071 |
| 2025-03-1020:19 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-036329 |
| 2025-03-1020:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036296 |
| 2025-03-0701:22 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000919574-25-001872 |
| 2025-03-0700:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-035821 |
| 2025-03-0421:28 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-045628 |
| 2025-02-0721:41 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-016378 |
| 2025-01-2822:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-009946 |
| 2024-12-1712:58 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-280112 |
| 2024-12-1712:24 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-280092 |
| 2024-11-0621:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122359 |
| 2024-11-0621:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122342 |
| 2024-09-1620:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-106817 |
| 2024-08-0820:24 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094059 |
| 2024-08-0820:14 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-093991 |
| 2024-07-2520:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-184817 |
| 2024-06-2721:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-078585 |
| 2024-05-3120:13 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-067318 |
| 2024-05-1420:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-059576 |
| 2024-05-1420:09 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0000950170-24-059539 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.